JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.C400613200 on March 8, 2005

J. Biol. Chem., Vol. 280, Issue 16, 15809-15814, April 22, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/16/15809    most recent
C400613200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loiarro, M.
Right arrow Articles by Ruggiero, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loiarro, M.
Right arrow Articles by Ruggiero, V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Peptide-mediated Interference of TIR Domain Dimerization in MyD88 Inhibits Interleukin-1-dependent Activation of NF-{kappa}B*

Maria Loiarro{ddagger}, Claudio Sette{ddagger}, Grazia Gallo§, Andrea Ciacci§, Nicola Fantò§, Domenico Mastroianni¶, Paolo Carminati§, and Vito Ruggiero§||

From the {ddagger}Department of Public Health and Cell Biology, University of Rome "Tor Vergata," 00173 Rome, Italy, the §Sigma-Tau Industrie Farmaceutiche Riunite S.p.A, 00040 Pomezia, Italy, and Tecnogen SCpA, 81015 Piana di Monte Verna (CE), Italy

Myeloid differentiation factor 88 (MyD88) plays a crucial role in the signaling pathways triggered by interleukin (IL)-1 and Toll-like receptors in several steps of innate host defense. A crucial event in this signaling pathway is represented by dimerization of MyD88, which allows the recruitment of downstream kinases like IRAK-1 and IRAK-4. Herein, we have investigated the function of the Toll/IL-1 receptor (TIR) domain in MyD88 homodimerization in cell-free and in vitro experimental settings by using epta-peptides that mimic the BB-loop region of the conserved TIR domain of different proteins. By using a pull-down assay with purified glutathione S-transferase-MyD88 TIR or co-immunoprecipitation experiments, we found that epta-peptides derived from the TIR domain of MyD88 and IL-18R are the most effective in inhibiting homodimerization with either the isolated TIR or full-length MyD88. Moreover, we demonstrated that a cell permeable analog of MyD88 epta-peptide inhibits homodimerization of MyD88 TIR domains in an in vitro cell system and significantly reduces IL-1 signaling, as assayed by activation of the downstream transcription factor NF-{kappa}B. Our results indicate that the BB-loop in TIR domain of MyD88 is a good target for specific inhibition of MyD88-mediated signaling in vivo.


Received for publication, December 27, 2004 , and in revised form, March 4, 2005.

* This work was supported by a Research Contract (Conto Terzi) from Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (to C. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A, Dept. of Immunology (Bldg. LABIO), Via Pontina km 30.400, 00040 Pomezia (RM), Italy. Tel.: 39-6-9139-4277; Fax: 39-6-9139-3988; E-mail: vito.ruggiero{at}Sigma-Tau.it.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Nyman, P. Stenmark, S. Flodin, I. Johansson, M. Hammarstrom, and P. Nordlund
The Crystal Structure of the Human Toll-like Receptor 10 Cytoplasmic Domain Reveals a Putative Signaling Dimer
J. Biol. Chem., May 2, 2008; 283(18): 11861 - 11865.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Funderburg, M. M. Lederman, Z. Feng, M. G. Drage, J. Jadlowsky, C. V. Harding, A. Weinberg, and S. F. Sieg
Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2
PNAS, November 20, 2007; 104(47): 18631 - 18635.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Loiarro, F. Capolunghi, N. Fanto, G. Gallo, S. Campo, B. Arseni, R. Carsetti, P. Carminati, R. De Santis, V. Ruggiero, et al.
Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound
J. Leukoc. Biol., October 1, 2007; 82(4): 801 - 810.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. Filipponi, R. M. Hobbs, S. Ottolenghi, P. Rossi, E. A. Jannini, P. P. Pandolfi, and S. Dolci
Repression of kit Expression by Plzf in Germ Cells
Mol. Cell. Biol., October 1, 2007; 27(19): 6770 - 6781.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. F. Rosenberg
Rational design of MyD88 inhibitors new pathways to inflammatory control: an interview with Dr. Claudio Sette
J. Leukoc. Biol., October 1, 2007; 82(4): 811 - 812.
[Full Text] [PDF]


Home page
J. Immunol.Home page
J. Fan, Y. Li, R. M. Levy, J. J. Fan, D. J. Hackam, Y. Vodovotz, H. Yang, K. J. Tracey, T. R. Billiar, and M. A. Wilson
Hemorrhagic Shock Induces NAD(P)H Oxidase Activation in Neutrophils: Role of HMGB1-TLR4 Signaling
J. Immunol., May 15, 2007; 178(10): 6573 - 6580.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Uto, X. Wang, K. Sato, M. Haraguchi, T. Akagi, M. Akashi, and M. Baba
Targeting of Antigen to Dendritic Cells with Poly({gamma}-Glutamic Acid) Nanoparticles Induces Antigen-Specific Humoral and Cellular Immunity
J. Immunol., March 1, 2007; 178(5): 2979 - 2986.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. K. Gautam, Ashish, L. D. Comeau, J. K. Krueger, and M. F. Smith Jr.
Structural and Functional Evidence for the Role of the TLR2 DD Loop in TLR1/TLR2 Heterodimerization and Signaling
J. Biol. Chem., October 6, 2006; 281(40): 30132 - 30142.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. V. Lasker and S. K. Nair
Intracellular TLR Signaling: A Structural Perspective on Human Disease
J. Immunol., July 1, 2006; 177(1): 11 - 16.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G. Canny, E. Cario, A. Lennartsson, U. Gullberg, C. Brennan, O. Levy, and S. P. Colgan
Functional and biochemical characterization of epithelial bactericidal/permeability-increasing protein
Am J Physiol Gastrointest Liver Physiol, March 1, 2006; 290(3): G557 - G567.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.